Clinical trial
Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary Syndrome
NCT00128180 · University of New Mexico, Other · Completed
Key facts
| NCT number | NCT00128180 |
|---|---|
| Title | Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary Syndrome |
| Official title | A Phase II Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Methylprednisolone as a Treatment for Presumed Hantavirus Cardiopulmonary Syndrome |
| Lead sponsor | University of New Mexico, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hantavirus Infections |
| Intervention type | Drug |
| Interventions | Methylprednisolone, Placebo |
| Enrollment | 66 |
| Start date | Jan 1, 2003 |
| Primary completion | Dec 1, 2010 |
| Completion | Oct 1, 2011 |
| First posted | Aug 9, 2005 |
| Last update posted | Dec 24, 2014 |
| Countries | Chile |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: